09.05.2017 • NewsElaine BurridgeIndiaPetrochemicals

HPCL and Mittal Plan Punjab Petchem Complex

(c) George Clerk/Getty Images
(c) George Clerk/Getty Images

Hindustan Petroleum Corp. (HPCL) and Indian steel magnate Lakshmi Mittal will invest about $3 billion to set up a petrochemical complex in Punjab, India, according to the Times of India newspaper.

HPCL-Mittal Energy (HMEL), a joint venture between HPCL and Mittal Energy Investments, plans to set up a naphtha cracker with an annual capacity of 1.2 million t, expandable to 1.7 million t, at the Bhatinda refinery. HPCL said it plans to fast-track the project in less than four years, but no firm timescale was disclosed.

The project is reported to be HPCL’s first petrochemical plant in northern India. The company has refineries in Mumbai and Visakhapatnam. HPCL and Mittal are equal partners in the Bhatinda refinery, which they also plan to expand but no further details were given.

HPCL chairman and managing director, Mukesh Kumar Surana, told the newspaper that land and other infrastructure were available at the refinery and the project would be formally announced shortly after receiving investment approvals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.